Skip to main content

. 1965 Aug 21;2(5459):453–455. doi: 10.1136/bmj.2.5459.453

Chlorphentermine S.A. in the Treatment of Obesity and the Effect of Weight Loss on Steroid Excretion

I M D Jackson, W G Whyte

PMCID: PMC1845864 PMID: 14314911

453

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

DUNCAN L. J., ROSE K., MEIKLEJOHN A. P. Phenmetrazine hydrochloride and methylcellulose in the treatment of "refractory" obesity. Lancet. 1960 Jun 11;1(7137):1262–1265. doi: 10.1016/s0140-6736(60)92249-2. [DOI] [PubMed] [Google Scholar]
HOLM T., HUUS I., KOPF R., MOLLER NIELSEN I., PETERSEN P. V. Pharmacology of a series of nuclear substituted phenyltertiary-butylamines with particular reference to anorexigenic and central stimulating properties. Acta Pharmacol Toxicol (Copenh) 1960;17:121–136. doi: 10.1111/j.1600-0773.1960.tb01236.x. [DOI] [PubMed] [Google Scholar]
LEVIN J., TRAFFORD J. A., NEWLAND P. M., BISHOP P. M. Chlorphentermine in the management of obesity. Practitioner. 1963 Jul;191:65–69. [PubMed] [Google Scholar]
LUCEY C., HADDEN D. R. Chlorphentermine: a new "appetite suppressant". A cross-over double-blind trial. Ulster Med J. 1962 Dec 1;31:181–184. [PMC free article] [PubMed] [Google Scholar]
MODELL W. Status and prospect of drugs for overeating. JAMA. 1960 Jul 9;173:1131–1136. doi: 10.1001/jama.1960.73020280008015. [DOI] [PubMed] [Google Scholar]
SEATON D. A., ROSE K., DUNCAN L. J. CURRENT THERAPEUTICS. 203. SUSTAINED-ACTION CHLORPHENTERMINE IN THE CORRECTION OF REFRACTORY OBESITY. Practitioner. 1964 Nov;193:698–702. [PubMed] [Google Scholar]
SUMMERS V. K., SHEEHAN H. L., HIPKIN L. J., DAVIS J. C. DIFFERENTIAL DIAGNOSIS OF CUSHING'S SYNDROME AND OBESITY ASSOCIATED WITH STRIAE. Lancet. 1964 Nov 21;2(7369):1079–1082. doi: 10.1016/s0140-6736(64)92606-6. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES